Prospective randomized trial of sclerotherapy vs standard treatment for epistaxis due to hereditary hemorrhagic telangiectasia

Publisher： John Wiley & Sons Inc

E-ISSN： 2042-6984|5|5|435-440

ISSN： 2042-6976

Source： INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, Vol.5, Iss.5, 2015-05, pp. : 435-440

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intranasal submucosal bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia: A double‐blind, randomized, placebo‐controlled trial

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 6, 2015-06 ,pp. : 783-787

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of lower extremity telangiectasias in women by foam sclerotherapy vs. Nd:YAG laser: a prospective, comparative, randomized, open‐label trial

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 3, 2015-03 ,pp. : 549-554

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Lung in Hereditary Hemorrhagic Telangiectasia

By  

Respiration, Vol. 94, Iss. 4, 2017-08 ,pp. : 315-330

Karger

Access to resources Recommend Favorite

Angiogenesis and Hereditary Hemorrhagic Telangiectasia

By  

Acta Haematologica, Vol. 106, Iss. 4, 2002-01 ,pp. : 214-219

Karger

Access to resources Recommend Favorite

Pulmonary Hypertension in a Large Cohort with Hereditary Hemorrhagic Telangiectasia

By  

Respiration, Vol. 94, Iss. 3, 2017-07 ,pp. : 242-250

Karger

Access to resources Recommend Favorite